SPP1 and osteosarcoma: This study aimed 1) to assess the serum OPN level as a marker for severity in primary osteogenic sarcoma, 2) to assess the serum OPN level as a marker for metastasis in primary osteogenic sarcoma, and 3) to assess the serum OPN level as a marker for therapeutic outcome in primary osteogenic sarcoma.